Skip to main content

Interferon Studies in Non-Human Primates

  • Chapter
Clinical Aspects of Interferons

Part of the book series: Developments in Medical Virology ((DIMV,volume 4))

Abstract

Biological response modifiers have multiple biological effects. Therefore, results obtained in vitro cannot be directly extrapolated to the therapeutic efficacy in humans. So animal studies are an essential prerequisite for the successful application of these agents in man. Interferons show a high degree of species specificity. Human interferon preparations are not active in “standard” laboratory animals as rats and mice. For studies in these species interferons from rat and mouse origin have to be produced. Initially the rodent interferons were produced from induced cell culture systems, which did not provide enough material for all the necessary studies. Recombinant DNA technology did not only solve the problem of production of human interferon, but also a number of animal interferons can now be produced in unlimited amounts (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Schellekens, H. and Meide, P.H. van der. In: The Interferon System, a current review (Baron et al., eds.), The University of Texas Press, 1987, in press.

    Google Scholar 

  2. Andrews, R.D. Brit. Med. J. 1728: 1728–1730, 1961.

    Article  Google Scholar 

  3. Falcoff, R., Falcoff, E., Duboche, P. et Chany, C. CR. Acad. Sc. Paris, t. 266, Série D: 297–300, 1968.

    CAS  Google Scholar 

  4. Pinto, CA., Haff, R.F., Valenta, J.R., Pagano, J.F., DiCuollo, C.J. and Ferlauto, R.J., In: Symp. Series Immunobiol. Standard., vol. 14: 105–112, Karger, Basel/New York, 1970.

    Google Scholar 

  5. Neumann-Haefelin, D., Sundmacher, R., Sauter, B., Karges, H.E. and Manthey, K.F. Infection and Immunity 12, no. 1: 148–155, 1975.

    PubMed  CAS  Google Scholar 

  6. Neumann-Haefelin, D., Shrestha, B. and Manthey, K.F. J. Infect. Dis. 133: A211-A216, 1976.

    Article  Google Scholar 

  7. Schellekens, H., Weimar, W., Cantell, K. and Stitz, L. Nature 278: 742, 1979.

    Article  PubMed  CAS  Google Scholar 

  8. Schellekens, H., Stitz, L.W., Reus, A. de, Weimar, W. and Cantell, K. Antiviral Res. 1: 281–285, 1981a.

    Article  Google Scholar 

  9. Schellekens, H., Reus, A. de, Bolhuis, R., Fountoulakis, M., Schein, C, Ecsödi, J., Nagata, S. and Weissmann, C. Nature 292:775–776, 1981b.

    Google Scholar 

  10. Weimar, W., Stitz, L., Billiau, A., Cantell, K. and Schellekens, H. J. gen. Virol. 48: 25–30, 1980.

    Article  PubMed  CAS  Google Scholar 

  11. Meide, P.H. van der, Harteveld, N., Stebbing, N. and Schellekens, H. Antiviral Res., suppl. 1: 199–207, 1985.

    Google Scholar 

  12. Finter, N.B. Interferons and interferon inducers. Elsevier Publishing company, Amsterdam, London, New York, 1973.

    Google Scholar 

  13. Hilfenhaus, J., Karges, H.E., Weinmann, E. and Barth, R. Infect. Imm. 11, no. 5: 1156–1158, 1975.

    CAS  Google Scholar 

  14. Hilfenhaus, J., Weinmann, E., Majer, M., Barth, R. and Jaeger, O. J. Infect. Dis. 135, no. 5: 846–849, 1977.

    Article  CAS  Google Scholar 

  15. Bear, CM., Shaddock, J.H., Moore, S.A., Yager, P.A., Baron, S.S., Levy, H.B. J. Infect. Dis. 136, 286–291, 1977.

    Article  Google Scholar 

  16. Arvin, A.M., Martin, D.P., Gard, E.A. and Merigan, T.C. J. Infect. Dis. 147, no. 1: 149–154, 1983.

    Article  CAS  Google Scholar 

  17. Desmyter, J., Groote, J. de, Desmet, V.J., Ray, M.B., Bradburne, A.F., Edy, V.G., Somer, P. de and Mortelmans, J. Lancet 645–647, 1976.

    Google Scholar 

  18. Goeddel, D.V., Yelverton, E., Ullrich, A., Heyneker, H.L., Miozzari, G., Holmes, W., Seeburg, P.H., Dull, T., May, L., Stebbing, N., Crea, R., Maeda, S., McCandliss, R., Sloma, A., Tabor, J.M., Gross, M., Familletti, P.C. and Pestka, S. Nature 287: 411–416, 1980.

    Article  PubMed  CAS  Google Scholar 

  19. Week, P.K., Harkins, R.N. and Stebbing, N. J. gen. Virol. 64: 415–419, 1983.

    Article  Google Scholar 

  20. Stebbing, N., Week, P.K., Fenno, J.T., Estell, D.A. and Rinderknecht, E. Arch. Virol. 76: 365–372, 1983.

    Article  PubMed  CAS  Google Scholar 

  21. Levin, R., Yaari, A., Gitelman, J., Bino, T., Rosenberg, H. and Kohn, A. Antiviral Res. 6: 277–283, 1986.

    Article  PubMed  CAS  Google Scholar 

  22. Sugar, J., Kaufman, H.E. and Varnell, E.D. Invest. Ophthalmol. 12: 378380, 1973.

    Google Scholar 

  23. Neumann-Haefelin, D., Sundmacher, R., Skoda, R. and Cantell, K. (1977) Infect. Imm. 17, no. 2: 468–470, 1977.

    CAS  Google Scholar 

  24. Neumann-Haefelin, D., Sundmacher, R., Frey, H. and Merk, W. Med. Microbiol. Immunol. 174; 81–86, 1985.

    Article  CAS  Google Scholar 

  25. Ferreira, A., Schofield, L., Enea, V., Schellekens, H., Meide, P., Collins, W.E., Nussenzweig, R.S. and Nussenzweig, V. Science 232: 881–884, 1986.

    Article  PubMed  CAS  Google Scholar 

  26. Schellekens, H., Eerd, P.M.C.A. van, Reus, A. de, Weck, P.K. and Stebbing, N. Antiviral Res. 2: 313–318, 1982.

    Article  PubMed  CAS  Google Scholar 

  27. Soike, K.F., Kramer, M.J. and Gerone, P.J. J. Infect. Dis. 147, no. 5: 933–938, 1983.

    Article  CAS  Google Scholar 

  28. Habif, D.V., Lipton, R. and Cantell, K. Proc. Soc. Exp. Biol. Med. 149, 287–289, 1975.

    PubMed  CAS  Google Scholar 

  29. Wills, R.J., Spiegel, H.E. and Soike, K.F. J. Interferon Research 4, 399–409, 1984.

    Article  CAS  Google Scholar 

  30. Collins, J.M., Riccardi, R., Trown, P., O’Neill, D. and Poplack, D.G. Cancer Drug Delivery 2, 247–253, 1985.

    Article  PubMed  CAS  Google Scholar 

  31. Skreko, F., Zajac, I., Bahnsen, H.P., Haff, R.F. and Cantell, K. Proc. Soc. Exper. Biol. Med. 142, 946–947, 1973.

    CAS  Google Scholar 

  32. Yamazaki, S., Kohase, M., Tatsumi, N., Onishi, E. et al. In: The clinical potential of interferons. Eds. R. Kono and J. Vilcek. Univ. Tokyo Press, pp. 281–293, 1981.

    Google Scholar 

  33. Bino, T., Edery, H., Gertler, A. and Rosenberg, H. J. gen. Virol. 59, 39–45, 1982.

    Article  PubMed  CAS  Google Scholar 

  34. Hilfenhaus, J., Damm, H., Hofstaetter, T., Mauler, R. et al. J. Interferon Res. 1, 427–436, 1981.

    Article  PubMed  CAS  Google Scholar 

  35. Gomi, K., Morimoto, M., Inoue, A., Kobayashi, H. et al. Gann 75., 292–300, 1984.

    PubMed  CAS  Google Scholar 

  36. Edy, V.G., Billiau, A. and De Somer, P. Lancet i, 451–452, 1978.

    Article  Google Scholar 

  37. Billiau, A., De Somer, P., Edy, V.G., De Clercq, E. and Heremans, H. Antimicr. Agents Chemother. 16, 56–63, 1979.

    CAS  Google Scholar 

  38. Vilcek, J., Sulea, I.T., Zerebreckyj, I.L. and Yip, Y.K. J. Clin. Microbiol. 11, 102–105, 1980.

    CAS  Google Scholar 

  39. Gutterman, J.U., Fine, S., Quesada, J., Horning, S.J. et al. Ann. Internal Med. 96, 549–556, 1982.

    CAS  Google Scholar 

  40. Cantell, K., Hirvonen, S., Pyhälä, L., De Reus, A. and Schellekens, H. J. gen. Virol. 64., 1823–1826, 1983.

    Google Scholar 

  41. Dawson, A., Hirsch, M., Otto, B., De Reus, A. and Schellekens, A. In: The biology of the interferon system. E. de Maeyer and H. Schellekens, eds., pp. 449–452, 1983.

    Google Scholar 

  42. Billiau, A., Heremans, H., Ververken, D., Van Damme, J., Carton, H. and De Somer, P. Archives of Virol. 68, 19–25, 1981.

    Article  CAS  Google Scholar 

  43. Kurzrock, R., Rosenblum, M.G., Sherwin, S.A., Rios, A. et al. Cancer Res. 45, 2866–2872, 1985.

    PubMed  CAS  Google Scholar 

  44. Pestka, S., Kelder, B., Familletti, P.C., Moschera, J.A. et al. J. Biol. Chem. 258, 9706–9709, 1983.

    PubMed  CAS  Google Scholar 

  45. Finter, N.B., Woodrooffe, J. and Priestman, T.J.: Nature 298: 301, 1982.

    Article  PubMed  CAS  Google Scholar 

  46. Weissmann, C. and Schellekens, H.: Nature 298: 301, 1982.

    Article  Google Scholar 

  47. Yamada, H., Nishiuchi, M., Sato, K., Kobayashi, F., Harada, Y., Bannai, H., Tatsumi, M. and Yamazaki, S. In: Interferons. Proc. of the Int. Symp. on Interferons (Kishida, T., ed.)278–285, 1984.

    Google Scholar 

  48. Schellekens, H.: In: Interferons, UCLA Symposia on Mol. and Cell. Biol. XXV (Merigan, T.C. et al., eds.), Academic Press, 1982, pp. 387–392.

    Google Scholar 

  49. Schellekens, H., Reus, A. de and Meide, P.H. v.d. J. Med. Primatol. 13: 235–245, 1984.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Kluwer Academic Publishers, Boston

About this chapter

Cite this chapter

Schellekens, H., Van Der Meide, P.H., Nooter, K. (1988). Interferon Studies in Non-Human Primates. In: Revel, M. (eds) Clinical Aspects of Interferons. Developments in Medical Virology, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1737-1_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1737-1_22

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8977-7

  • Online ISBN: 978-1-4613-1737-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics